| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/04/2001 | EP1112066A2 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 07/04/2001 | EP1112065A1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative |
| 07/04/2001 | EP1112064A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications |
| 07/04/2001 | EP1112063A1 Lipstatin derivative-soluble fiber tablets |
| 07/04/2001 | EP1112062A1 Mousse composition |
| 07/04/2001 | EP1112061A1 Drug preparations for treating sexual dysfunction |
| 07/04/2001 | EP1112060A1 Dosage form comprising liquid formulation |
| 07/04/2001 | EP1111995A1 Topical dermal antimicrobial compositions |
| 07/04/2001 | EP0969832B1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates |
| 07/04/2001 | EP0902777B1 D-mannitol and its preparation |
| 07/04/2001 | EP0789586B1 Compounds for the prevention and treatment of helminth infections |
| 07/04/2001 | EP0760651B1 Pharmaceutical compositions derived from microelmulsion-based gels, method for their preparation and new microemulsion-based gels |
| 07/04/2001 | EP0706370B1 Stable topical retinoid compositions |
| 07/04/2001 | CN1302209A Polyol-IFN-beta conjugates |
| 07/04/2001 | CN1302203A Spray-dried powders with high edible-oil loading based on non-hydrolyzed gelatin and method of making such spry-dried tablettable powders |
| 07/04/2001 | CN1302202A Opthalmic solution comprising glycogen |
| 07/04/2001 | CN1302201A Ophthalmic compositions containing galactomannan polymers and borate |
| 07/04/2001 | CN1302199A Artificial nail compositions and related methods |
| 07/04/2001 | CN1302183A Xylitol compositions for treating upper respiratory conditions |
| 07/04/2001 | CN1301534A Stable slow-releasing oral administration composition |
| 07/03/2001 | US6255502 Pharmaceutical composition containing acid addition salt of basic drug |
| 07/03/2001 | US6255481 Treating aqueous suspension of anhydrous nevirapine with hydrochloric acid then treating with sodium hydroxide yields the free base as a precipitate/hemihydrate which is then filtered from solution and water washed |
| 07/03/2001 | US6255457 Immunoglobulin for use as diagnositic tool and in preferential drug delivery |
| 07/03/2001 | US6255332 Use of oxazolidinone derivatives as anti-penetrating agents in a cosmetic and/or dermatological composition |
| 07/03/2001 | US6255294 Absorption by mucous membrane |
| 07/03/2001 | US6255290 Reducing sensitivity to skin cancer; topical administering of nucleotide |
| 07/03/2001 | US6255284 Pharmaceutical composition |
| 07/03/2001 | US6255277 Localized use of nitric oxide-adducts to prevent internal tissue damage |
| 07/03/2001 | US6254892 Pellet formulations |
| 07/03/2001 | US6254887 Controlled release tramadol |
| 07/03/2001 | US6254885 Containing: cyclosporin, ethanol or propylene glycol, non-ionic polyoxyalkylene surfactant, cosolvent; high bioavailability, used in immuno-suppressive therapy |
| 07/03/2001 | US6254884 Somatotropin compositions mixed with vitamins |
| 07/03/2001 | US6254883 Composition for transdermal delivery of drugs |
| 07/03/2001 | US6254877 Transfer-free cosmetic composition comprising a dispersion of non-film-forming polymer particles in a partially nonvolatile liquid fatty phase |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | US6254860 Ocular treatment using cyclosporin-A derivatives |
| 07/03/2001 | US6254851 Diagnostic agents for pancreatic exocrine function |
| 07/03/2001 | CA2181359C Treatment of antibiotic associated diarrhea |
| 07/03/2001 | CA2166891C Method for making freeze dried drug dosage forms |
| 07/03/2001 | CA2141704C Concentrated aqueous argatroban solutions |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2116563C Dry gel pharmaceutical composition |
| 07/03/2001 | CA2098108C Water dispersible tablets |
| 07/03/2001 | CA2077641C Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/28/2001 | WO2001046355A1 Stabilisation of pigments and polyunsaturated oils and oil concentrates |
| 06/28/2001 | WO2001046291A1 Sterically hindered derivatives of water soluble polymers |
| 06/28/2001 | WO2001046265A1 Water insoluble derivatives of polyanionic polysaccharides |
| 06/28/2001 | WO2001046223A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001045796A2 Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045745A2 A reversible linkage technology for controlled conjugation |
| 06/28/2001 | WO2001045744A2 Novel compounds of unsaturated fatty acids |
| 06/28/2001 | WO2001045743A2 Use of an enzyme to improve the resorption of medicaments in the tissue |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045741A2 Methods for preparing pharmaceutical formulations |
| 06/28/2001 | WO2001045727A2 Stabilized veterinary compositions comprising more than one antiviral agent |
| 06/28/2001 | WO2001045713A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 06/28/2001 | WO2001045706A1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 06/28/2001 | WO2001045705A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | WO2001045695A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 06/28/2001 | WO2001045679A2 Use of chemotherapeutic agents for topical treatment |
| 06/28/2001 | WO2001045677A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045676A2 Extended release oral dosage composition |
| 06/28/2001 | WO2001045674A1 Process for producing nanometer particles by fluid bed spray-drying |
| 06/28/2001 | WO2001045671A2 Suspension comprising oxcarbazepine |
| 06/28/2001 | WO2001045670A2 A stable immunogenic composition for frozen storage |
| 06/28/2001 | WO2001045668A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 06/28/2001 | WO2001045667A2 Water-soluble powders for oral solution and use thereof |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045645A1 Chitosan biopolymer for the topical delivery of active agents |
| 06/28/2001 | WO2001045599A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 06/28/2001 | WO2001045577A2 Intervertebral disc treatment devices and methods |
| 06/28/2001 | WO2001003686A3 Inhibitors of staphylococcus sara protein and their use in treating staphylococcal infections |
| 06/28/2001 | WO2000078357A3 Hyaluronic acid film and matrix for sustained gene transfer |
| 06/28/2001 | WO2000073333A3 Ligand for cd7, and methods for use thereof |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000042987A8 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 06/28/2001 | WO2000027437A9 Polymer grafting by polysaccharide synthases |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | US20010005747 Bispecific molecules comprising a target cell specific ligand and an effector cell specific antibody or functional antibody fragment |
| 06/28/2001 | US20010005726 Includes an organic solvent, a surfactant, and an oil; high in vivo bioavailability |
| 06/28/2001 | US20010005720 Method of treating chronic progressive vascular scarring diseases |
| 06/28/2001 | US20010005717 Gene transfer complexes of a polyethyleneimine having a hydrophilic polymer such as polyoxyethylene glycol coupled thereto, and a nucleic acid; use in gene therapy |
| 06/28/2001 | US20010005716 Core of an acid labile medicant such as didanosine, a binder and a disintegrant, and a coating of a methacrylic acid copolymer and plasticizer which protects drug at low pH but releases drug at pH of 4.5 or higher, anti-adherent |
| 06/28/2001 | US20010005714 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 06/28/2001 | US20010005713 Use of heat shock proteins to deliver moieties into cells |
| 06/28/2001 | US20010005514 L-ascorbic acid and pectin composition |
| 06/28/2001 | US20010005513 With water insoluble starch carrier; allows dry storage and lower doses of active ingredient |
| 06/28/2001 | US20010005502 Monofluoro phosphorylated macromolecules |
| 06/28/2001 | US20010005501 A pharmaceutical composition comprising a mixture of hyaluronic acid and liposomes, and is free of superoxide dismutase; improves stability of liposomes; gene therapy; cyclosporin A delivery |
| 06/28/2001 | DE19961897A1 Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen Using a film coating as taste coating of pharmaceutical dosage forms |
| 06/28/2001 | CA2717246A1 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2394901A1 Chitosan biopolymer for the topical delivery of active agents |
| 06/28/2001 | CA2394877A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | CA2394582A1 Water insoluble derivatives of polyanionic polysaccharides |
| 06/28/2001 | CA2394568A1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |